No Data
No Data
Myriad Genetics Price Target Lowered to $9 From $11 at BofA
Myriad Genetics Cut to Neutral From Buy by Guggenheim
Guggenheim Downgrades Myriad Genetics(MYGN.US) to Hold Rating
Press Release: Myriad Genetics Announces Inducement Awards
Press Release: Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
Express News | Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer